Clinical Trials Browser

Phase 1/2 × Lymphoma, Non-Hodgkin × copanlisib × Clear all

NCT02342665 2023-01-20

Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL

Phase 1/2 Completed

Lymphoma, Non-Hodgkin